logo

For the Inventor, By the Inventor

Barcelona, Spain

Ricardo Granados Jarque

This inventor holds 12 USPTO granted patents. Top assignees: Laboratorios Made, S.a., Laboratories Made, S.a.. Active years: 1976-1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ricardo Granados Jarque. Retrieved from https://idiyas.com/inventor/ricardo-granados-jarque

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Barcelona, E (1976)
  • Barcelona, ES (1977 - 1979)

Company Filing History:

goldMedal9 out of 14 
 
Laboratorios Made, S.a.
 patents
silverMedal3 out of 5 
 
Laboratories Made, S.a.
 patents

Years Active: 1976-1979

Loading Chart...
12 patents (USPTO):Explore Patents
1. 4179565 - 2,5-Dimethyl-benzo[b]-thieno[2,3-f]morphan and precursors thereof (1979-12-18),
2. 4178450 - 2,5-Dimethyl-benzo(b) thiene (3,2-f) morphan and precursor thereof (1979-12-11),
3. 4174451 - 2-Furyl-(3,4-dimethyl-2-pyridyl)-carbinol (1979-11-13),
4. 4173705 - 2-(2-Furoyl)-4-methylpyridine and its methyl iodide quaternary salt (1979-11-06),
5. 4172894 - 3-Thienyl-3-methyl-4-pentyl-2-pyridyl-ketone (1979-10-30),
6. 4172201 - Alpha-2,5,9-trimethyl-benzo(b)thiene(2,3-f)morphan and precursor thereof (1979-10-23),
7. 4145424 - 1,4,4A-Trimethyl-1,2,4a,-4b,9a,10a-hexahydro-10H-benzo �b! thieno (1979-03-20),
8. 4111945 - Process for the preparation of (1978-09-05),
9. 4029799 - Certain analgesically active substituted benzyl pyridine compounds (1977-06-14),
10. 4028371 - The compound (1977-06-07),
11. 4001414 - 1,3,4-Trimethyl-2-(3,4,5-trimethoxybenzyl)-1,2,5,6-tetrahydropyridine (1977-01-04),
12. 4000283 - Compound 3,4,5-trimethoxyphenyl-(3,4-dimethyl-2-pyridyl)-carbonyl (1976-12-28),

Title: Innovator Ricardo Granados Jarque: A Pioneer in Analgesic Agents

Introduction: Ricardo Granados Jarque is a distinguished inventor based in Barcelona, ES, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 11 patents, Granados Jarque has made noteworthy advancements, particularly in the development of analgesic compounds.

Latest Patents: Among his latest patents, Ricardo Granados Jarque has developed two major compounds: 2,5-Dimethyl-benzo[b]-thieno[2,3-f]morphan and precursors thereof, alongside another compound, 2-(3-benzo[b]thienylmethyl)-1,4-dimethyl-1,2,3,6-tetrahydropyridine. These innovations are specifically designed for analgesic applications, illustrating the inventor's commitment to improving pain management solutions. Furthermore, he has patented 2,5-Dimethyl-benzo[b]thiene[3,2-f]morphan and precursors thereof, enhancing the pharmacological landscape in the analgesic domain.

Career Highlights: Ricardo Granados Jarque's career has been marked by his tenure at Laboratorios Made, S.A., where he honed his skills and expertise in pharmaceutical research and development. His dedication to innovation has positioned him as a key figure in the creation of therapeutic agents that contribute to better health outcomes.

Collaborations: Throughout his career, Granados Jarque has collaborated with esteemed professionals including Juan Bosch Cartes and Fernando Rabadan Peinado. These partnerships have fostered a collaborative environment that promotes innovative thinking and research exploration.

Conclusion: Ricardo Granados Jarque stands out as a formidable inventor in the pharmaceutical field, with his numerous patents affirming his contribution to pain management and therapeutic advancements. His continued efforts and collaborative spirit are expected to inspire future innovations that will further enhance healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…